Endoscopic ultrasound diagnostic gain over computed tomography and magnetic resonance cholangiopancreatography in defining etiology of idiopathic acute pancreatitis
- PMID: 35978715
- PMCID: PMC9265256
- DOI: 10.4253/wjge.v14.i6.0000
Endoscopic ultrasound diagnostic gain over computed tomography and magnetic resonance cholangiopancreatography in defining etiology of idiopathic acute pancreatitis
Abstract
Background: About 10%-30% of acute pancreatitis remain idiopathic (IAP) even after clinical and imaging tests, including abdominal ultrasound (US), contrast-enhanced computed tomography (CECT) and magnetic resonance cholangiopancreatography (MRCP). This is a relevant issue, as up to 20% of patients with IAP have recurrent episodes and 26% of them develop chronic pancreatitis. Few data are available on the role of EUS in clarifying the etiology of IAP after failure of one or more cross-sectional techniques.
Aim: To evaluate the diagnostic gain after failure of one or more previous cross-sectional exams.
Methods: We retrospectively collected data about consecutive patients with AP and at least one negative test between US, CECT and MRCP, who underwent linear EUS between January 2017 and December 2020. We investigated the EUS diagnostic yield and the EUS diagnostic gain over different combinations of these cross-sectional imaging techniques for the etiologic diagnosis of AP. Types and frequency of EUS diagnosis were also analyzed, and EUS diagnosis was compared with the clinical parameters. After EUS, patients were followed-up for a median of 31.5 mo to detect cases of pancreatitis recurrence.
Results: We enrolled 81 patients (63% males, mean age 61 ± 18, 23% with previous cholecystectomy, 17% with recurrent pancreatitis). Overall EUS diagnostic yield for AP etiological diagnosis was 79% (20% lithiasis, 31% acute on chronic pancreatitis, 14% pancreatic solid or cystic lesions, 5% pancreas divisum, 5% autoimmune pancreatitis, 5% ductal abnormalities), while 21% remained idiopathic. US, CECT and MRCP, taken alone or in combination, led to AP etiological diagnosis in 16 (20%) patients; among the remaining 65 patients, 49 (75%) obtained a diagnosis at EUS, with an overall EUS diagnostic gain of 61%. Sixty-eight patients had negative US; among them, EUS allowed etiological diagnosis in 59 (87%). Sixty-three patients had a negative CECT; among them, 47 (74%) obtained diagnosis with EUS. Twenty-four had a negative MRCP; among them, 20 (83%) had EUS diagnosis. Twenty-one had negative CT + MRCP, of which 17 (81%) had EUS diagnosis, with a EUS diagnostic gain of 63%. Patients with biliary etiology and without previous cholecystectomy had higher median values of alanine aminotransferase (154 vs 25, P = 0.010), aspartate aminotransferase (95 vs 29, P = 0.018), direct bilirubin (1.2 vs 0.6, P = 0.015), gamma-glutamyl transpeptidase (180 vs 48, P = 0.006) and alkaline phosphatase (150 vs 72, P = 0.015) Chronic pancreatitis diagnosis was more frequent in patients with recurrent pancreatitis at baseline (82% vs 21%, P < 0.001). During the follow-up, AP recurred in 3 patients, one of which remained idiopathic.
Conclusion: EUS is a good test to define AP etiology. It showed a 63% diagnostic gain over CECT + MRCP. In suitable patients, EUS should always be performed in cases of IAP. Further prospective studies are needed.
Keywords: Computed tomography; Diagnostic gain; Endoscopic ultrasound; Idiopathic acute pancreatitis; Magnetic resonance cholangiopancreatography.
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: All authors have no financial relationships to disclose.
Figures

Similar articles
-
Idiopathic acute pancreatitis-A myth or reality? Role of endoscopic ultrasonography and magnetic resonance cholangiopancreatography in its diagnosis.Indian J Gastroenterol. 2021 Feb;40(1):22-29. doi: 10.1007/s12664-020-01125-9. Epub 2021 Feb 6. Indian J Gastroenterol. 2021. PMID: 33548019
-
Prospective comparison of endoscopic ultrasonography and magnetic resonance cholangiopancreatography in the etiological diagnosis of "idiopathic" acute pancreatitis.Pancreas. 2011 Mar;40(2):289-94. doi: 10.1097/MPA.0b013e318201654a. Pancreas. 2011. PMID: 21206330
-
EUS is superior to secretin-enhanced cholangio-MRI to establish the etiology of idiopathic acute pancreatitis.Endosc Int Open. 2020 Oct;8(10):E1441-E1447. doi: 10.1055/a-1233-1849. Epub 2020 Oct 7. Endosc Int Open. 2020. PMID: 33043111 Free PMC article.
-
Endoscopic Ultrasound for Routine Assessment in Idiopathic Acute Pancreatitis.J Gastrointest Surg. 2019 Aug;23(8):1694-1700. doi: 10.1007/s11605-019-04272-3. Epub 2019 Jun 13. J Gastrointest Surg. 2019. PMID: 31197695
-
Role of endoscopic ultrasound in idiopathic pancreatitis.World J Gastroenterol. 2017 Oct 14;23(38):6952-6961. doi: 10.3748/wjg.v23.i38.6952. World J Gastroenterol. 2017. PMID: 29097868 Free PMC article. Review.
Cited by
-
Acute Necrotizing Pancreatitis-Advances and Challenges in Management for Optimal Clinical Outcomes.Medicina (Kaunas). 2025 Jun 30;61(7):1186. doi: 10.3390/medicina61071186. Medicina (Kaunas). 2025. PMID: 40731816 Free PMC article. Review.
-
Infected Walled-Off Necrosis Following COVID-19-Associated Acute Pancreatitis.Cureus. 2024 Jan 8;16(1):e51889. doi: 10.7759/cureus.51889. eCollection 2024 Jan. Cureus. 2024. PMID: 38327952 Free PMC article.
-
Endoscopic Ultrasound in Pancreatology: Focus on Inflammatory Diseases and Interventions.Visc Med. 2023 Oct;39(5):131-139. doi: 10.1159/000533433. Epub 2023 Sep 5. Visc Med. 2023. PMID: 37899796 Free PMC article. Review.
-
Idiopathic mesenteric phlebosclerosis: a rare but important disease in Asian populations.Eur J Med Res. 2025 Apr 1;30(1):219. doi: 10.1186/s40001-025-02505-7. Eur J Med Res. 2025. PMID: 40170103 Free PMC article. Review.
References
-
- Singh VK, Bollen TL, Wu BU, Repas K, Maurer R, Yu S, Mortele KJ, Conwell DL, Banks PA. An assessment of the severity of interstitial pancreatitis. Clin Gastroenterol Hepatol . 2011;9:1098–1103. - PubMed
-
- van Santvoort HC, Bakker OJ, Bollen TL, Besselink MG, Ahmed Ali U, Schrijver AM, Boermeester MA, van Goor H, Dejong CH, van Eijck CH, van Ramshorst B, Schaapherder AF, van der Harst E, Hofker S, Nieuwenhuijs VB, Brink MA, Kruyt PM, Manusama ER, van der Schelling GP, Karsten T, Hesselink EJ, van Laarhoven CJ, Rosman C, Bosscha K, de Wit RJ, Houdijk AP, Cuesta MA, Wahab PJ, Gooszen HG Dutch Pancreatitis Study Group. A conservative and minimally invasive approach to necrotizing pancreatitis improves outcome. Gastroenterology . 2011;141:1254–1263. - PubMed
-
- Boxhoorn L, Voermans RP, Bouwense SA, Bruno MJ, Verdonk RC, Boermeester MA, van Santvoort HC, Besselink MG. Acute pancreatitis. Lancet . 2020;396:726–734. - PubMed
-
- Guda NM, Trikudanathan G, Freeman ML. Idiopathic recurrent acute pancreatitis. Lancet Gastroenterol Hepatol . 2018;3:720–728. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials